About Pow.Bio
Pow.Bio is a Healthcare company based in Berkeley (United States) founded in 2019 by Shannon Hall and Ouwei Wang. It operates as an intelligent fermentation services for industrial and synthetic biology are provided. Pow.Bio has raised $9.5 million across 1 funding round from investors including iSelect, Thia Ventures and Hitachi Ventures. Its chief executive is Charlie Emrich. Pow.Bio offers products and services including Fermentation Platform and High-Efficiency System. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioreactors. Its competitors include Unibio, Univercells Tech, Nirrin Technologies, Caladan Bio and BiOZEEN and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Pow.Bio was founded in 2019 as a biotechnology company in Berkeley, United States. A fermentation platform has been developed to mitigate contamination and genetic drift issues in biomanufacturing processes. Growth phases are decoupled from production by this technology, facilitating scaled output of consistent products. Services are extended to industrial and synthetic biology applications.
- Total Equity Funding$9.5M (USD)
in 1 rounds
- Latest Funding Round$9.5M (USD), Series A
Oct 2023
- InvestorsiSelect
& 10 more
Products & Services of Pow.Bio
Pow.Bio offers a comprehensive portfolio of products and services, including Fermentation Platform and High-Efficiency System.
Enables continuous fermentation to reduce costs and boost productivity for bioproducts.
Optimizes biomanufacturing by decoupling growth and production processes.
Funding Insights of Pow.Bio
Pow.Bio has successfully raised a total of $9.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $9.5 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.5M
- Total Rounds 1
- Last Round Series A — $9.5M
- First Round $9.5M
(Oct 2023)
- Investors Count 11
All 1 funding rounds of Pow.Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $9.5M | Series A | – | Thia Ventures, Gullspang Re:food |
11 investors in total: 11 institutional.
Investors in Pow.Bio
Pow.Bio has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include iSelect, Thia Ventures and Hitachi Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund focused on healthcare startups | – | thiaventures.com | New York, United States | |
Venture capital funding is provided for technology and healthcare companies. | – | hitachi-ventures.com | Munich, Germany | |
Early-stage investments across multiple sectors are conducted by this firm. | – | possible.ventures | Munich, Germany | |
Early-stage capital is provided to women and mixed-gender founding teams. | – | xfactor.ventures | - | |
Venture capital is invested in climate tech startups and entrepreneurs. | – | climatecapital.co | San Francisco, United States | |
Micro-venture capital firm investing in pre-seed to seed stage startups | – | better.vc | Oakland, United States | |
Seed stage tech-focused VC firm investing primarily in the US | – | cantos.vc | San Francisco, United States | |
Seed and early-stage micro investments are targeted in the US. | – | beepartners.vc | San Francisco, United States | |
Growth equity investments are made in agrifood system transformation. | – | refood.co | - | |
Financial products and utilities are compared online by iSelect. | 1999 | iselect.com.au | Cheltenham, Australia |
Investor details for Pow.Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pow.Bio
8 people are tracked at Pow.Bio (5 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Shannon Hall | Co-Founder | Leadership |
Ouwei Wang | Co-Founder | Leadership |
Charlie Emrich | CEO | Leadership |
Kalpesh Parekh | Executive Vice President, Commercial | Leadership |
Daniel Dengrove | Chief Of Staff | Leadership |
Joshua Ursua | Facilities Manager | Team |
Paul Ferguson | Lab Operations Manager | Team |
Rachel Stein | Business Development Lead | Team |
Complete people profiles for Pow.Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pow.Bio
2 dated milestones of Pow.Bio across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Pow.Bio is founded.
- Funding First funding round of $9.5M.
Competitors of Pow.Bio
Pow.Bio has 8 listed competitors in our database, 4 of them funded. They include Unibio, Univercells Tech, Nirrin Technologies, Caladan Bio and BiOZEEN, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unibio.dk | 2001 | Odense, Denmark | $30M | 59 | Animal feed supplements are produced using proprietary fermentation technology. | |
| univercellstech.com | 2020 | Nivelles, Belgium | – | 74 | Intensified biomanufacturing technologies for viral production are developed and manufactured. | |
| nirrin.tech | 2018 | Billerica, United States | $4.82M | 17 | Developer of sensor and integration technologies for continuous control and bioprocess automation | |
| caladan.bio | 2023 | Brooklyn, United States | $5.11M | – | Modular bioreactors are developed for biotechnology research applications. | |
| biozeen.com | 2005 | Bengaluru, India | – | 194 | Customized bioprocess equipment and automation solutions are provided for biopharmaceuticals. | |
| dab.bio | 2012 | Delft, Netherlands | $2.23M | – | Technology solutions for accelerated fermentation of renewable feedstocks are provided. | |
| brightpathlabs.com | 2019 | Santa Fe, United States | – | – | Spinning tube-in-tube continuous-flow reactors are developed for drug manufacturing. | |
| tecnic.eu | 2011 | Girona, Spain | – | – | Bioprocess equipment is developed for cell culture and microbial applications. |
Detailed competitors of Pow.Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pow.Bio
The website of Pow.Bio (pow.bio) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 78.4% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Pow.Bio (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pow.Bio
Complete news archive for Pow.Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pow.Bio
Pow.Bio was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Pow.Bio is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Charlie Emrich is the current CEO of Pow.Bio.
Pow.Bio is a funded company, having raised a total of $9.5M across 1 funding round to date. The company's 1st funding round was a Series A of $9.5M, raised on Oct 2023.
Pow.Bio was founded in 2019 as a biotechnology company in Berkeley, United States. A fermentation platform has been developed to mitigate contamination and genetic drift issues in biomanufacturing processes. Growth phases are decoupled from production by this technology, facilitating scaled output of consistent products. Services are extended to industrial and synthetic biology applications.
Pow.Bio's top competitors include Unibio, Univercells Tech and Nirrin Technologies.
Pow.Bio offers Fermentation Platform and High-Efficiency System.
Pow.Bio has 11 investors. Key investors include iSelect, Thia Ventures, Hitachi Ventures, Possible Ventures, and XFactor Ventures.